A PERSONALIZED APPROACH TO PATIENTS DIAGNOSED WITH ADVANCED OR RECURRENT OVARIAN CANCER

ACCC, SGO
5/25/22, 3:00 PM
America/Chicago UTC -5

Description

This webinar will be dedicated to helping healthcare professionals treating patients with newly diagnosed ovarian cancer choose between neoadjuvant chemotherapy or upfront surgery. The webinar will also review the role of secondary cytoreduction in patients with recurrent ovarian cancer.

Following the webinar participants will be more familiar with:

1. The recommended clinical evaluation of patients with newly diagnosed advanced ovarian cancer
2. The patient and disease factors that may help identify patients who are not good candidates for upfront surgery
3. How do neoadjuvant and upfront surgery compare in regard to progression free survival, overall survival, and morbidity and mortality
4. The preferred chemotherapy regimens, number of cycles before interval cytoreduction
5. The recommended surgical algorithm to improve the rate of optimal surgical cytoreduction
6. Selecting patients with recurrent ovarian cancer who are most likely to benefit from a secondary cytoreduction.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

A PERSONALIZED APPROACH TO PATIENTS DIAGNOSED WITH ADVANCED OR RECURRENT OVARIAN CANCER

Inglês

 

Speakers

soon